Literature DB >> 23472230

Thyroid cancer cell line misidentification: an update.

Rebecca E Schweppe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23472230      PMCID： PMC3590476          DOI： 10.1210/jc.2012-4182

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  6 in total

1.  Short tandem repeat profiling provides an international reference standard for human cell lines.

Authors:  J R Masters; J A Thomson; B Daly-Burns; Y A Reid; W G Dirks; P Packer; L H Toji; T Ohno; H Tanabe; C F Arlett; L R Kelland; M Harrison; A Virmani; T H Ward; K L Ayres; P G Debenham
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

2.  Cancer cell line identification by short tandem repeat profiling: power and limitations.

Authors:  Walther Parson; Romana Kirchebner; Roswitha Mühlmann; Kathrin Renner; Anita Kofler; Stefan Schmidt; Reinhard Kofler
Journal:  FASEB J       Date:  2005-01-06       Impact factor: 5.191

3.  Cell biology. Cases of mistaken identity.

Authors:  Rhitu Chatterjee
Journal:  Science       Date:  2007-02-16       Impact factor: 47.728

4.  Misidentification of putative medullary thyroid cancer cell lines RO-H85-1 and RO-D81-1.

Authors:  Tikva Dadon; Douglas Ball; Barry D Nelkin
Journal:  J Clin Endocrinol Metab       Date:  2013-03       Impact factor: 5.958

5.  Human medullary thyroid carcinoma. Initial characterization and in vitro differentiation of two new cell lines.

Authors:  E Abemayor; N Sidell; G Juillard
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1989-04

6.  Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification.

Authors:  Rebecca E Schweppe; Joshua P Klopper; Christopher Korch; Umarani Pugazhenthi; Miriam Benezra; Jeffrey A Knauf; James A Fagin; Laura A Marlow; John A Copland; Robert C Smallridge; Bryan R Haugen
Journal:  J Clin Endocrinol Metab       Date:  2008-08-19       Impact factor: 5.958
  6 in total
  7 in total

1.  Reproducibility: changing the policies and culture of cell line authentication.

Authors:  Leonard P Freedman; Mark C Gibson; Stephen P Ethier; Howard R Soule; Richard M Neve; Yvonne A Reid
Journal:  Nat Methods       Date:  2015-06       Impact factor: 28.547

Review 2.  Establishment, authenticity, and characterization of cervical cancer cell lines.

Authors:  Ma de Lourdes Zuñiga Martinez; Carlos Miguel López Mendoza; Jared Tenorio Salazar; Alejandro Manuel García Carrancá; Marco Antonio Cerbón Cervantes; Luz Eugenia Alcántara-Quintana
Journal:  Mol Cell Oncol       Date:  2022-06-01

3.  GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.

Authors:  Xiaotian Yuan; Ninni Mu; Na Wang; Klas Strååt; Anastasios Sofiadis; Yanxia Guo; Adam Stenman; Kailin Li; Guanghui Cheng; Lu Zhang; Feng Kong; Lars Ekblad; Johan Wennerberg; Inga-Lena Nilsson; C Christofer Juhlin; Catharina Larsson; Dawei Xu
Journal:  Oncogene       Date:  2018-09-04       Impact factor: 9.867

4.  circPVT1 regulates medullary thyroid cancer growth and metastasis by targeting miR-455-5p to activate CXCL12/CXCR4 signaling.

Authors:  Xun Zheng; Shu Rui; Xiao-Fei Wang; Xiu-He Zou; Yan-Ping Gong; Zhi-Hui Li
Journal:  J Exp Clin Cancer Res       Date:  2021-05-07

5.  Detection of viral proteins in human cells lines by xeno-proteomics: elimination of the last valid excuse for not testing every cellular proteome dataset for viral proteins.

Authors:  Alexey L Chernobrovkin; Roman A Zubarev
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

6.  MiRNA expression may account for chronic but not for acute regulation of mRNA expression in human thyroid tumor models.

Authors:  Sébastien L Floor; Aline Hebrant; Jaime M Pita; Manuel Saiselet; Christophe Trésallet; Frederick Libert; Guy Andry; Jacques E Dumont; Wilma C van Staveren; Carine Maenhaut
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

7.  Demonstration of a potent RET transcriptional inhibitor for the treatment of medullary thyroid carcinoma based on an ellipticine derivative.

Authors:  Vishnu Muthuraj Kumarasamy; Daekyu Sun
Journal:  Int J Oncol       Date:  2017-05-11       Impact factor: 5.650
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.